Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating)'s stock price traded up 2.3% on Monday . The company traded as high as $0.44 and last traded at $0.44. 440,574 shares traded hands during trading, an increase of 11% from the average session volume of 396,540 shares. The stock had previously closed at $0.43.
Sio Gene Therapies Stock Performance
The stock's 50-day moving average is $0.38 and its two-hundred day moving average is $0.35.
Get Sio Gene Therapies alerts:Sio Gene Therapies (NASDAQ:SIOX – Get Rating) last released its quarterly earnings data on Thursday, November 10th. The company reported ($0.04) EPS for the quarter.
Hedge Funds Weigh In On Sio Gene Therapies
Several institutional investors have recently bought and sold shares of SIOX. Jane Street Group LLC bought a new stake in shares of Sio Gene Therapies in the 2nd quarter worth about $33,000. SVB Wealth LLC bought a new stake in shares of Sio Gene Therapies in the 3rd quarter worth about $26,000. Finally, Rubric Capital Management LP lifted its holdings in shares of Sio Gene Therapies by 16.5% in the 3rd quarter. Rubric Capital Management LP now owns 7,000,000 shares of the company's stock worth $1,960,000 after acquiring an additional 988,995 shares during the last quarter.About Sio Gene Therapies
(Get Rating)
Sio Gene Therapies, Inc is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focuses on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis, such as Tay-Sachs disease and Sandhoff disease.
Recommended Stories
- Get a free copy of the StockNews.com research report on Sio Gene Therapies (SIOX)
- Is the Worst Behind for Under Armor Stock with a New CEO?
- Analysts Like The Fit Of Skechers USA
- What Does Microsoft's Investment in ChatGBT Mean for MSFT Stock?
- Can We Trust The Rally In The S&P 500
- Energy Surge: Four Oil-And-Gas Stocks Setting Up In Bullish Bases
Receive News & Ratings for Sio Gene Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sio Gene Therapies and related companies with MarketBeat.com's FREE daily email newsletter.